David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, speaks on the lack of interventions to manage the underlying causes of exacerbation in atopic dermatitis.
There remains significant unmet needs in addressing the underlying causes of atopic dermatitis, said David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology.
Transcript
What are some of the unmet needs in atopic dermatitis? Do you think that these newer therapies will help or does more need to be done?
Right now, a lot of what we do is sort of like putting band-aids, literally, on some of our patients with the terrible skin that they have, and this really can decrease quality of life. In addition to the severe itch that can occur, the skin can undergo long-term damage and it can lead to decreased work and just the ability to do things that people love.
Imagine having terrible eczema affecting your hands and it decreases your ability to do crafting, woodworking, or whatever you want to do, what your passion is. So, we need better options that really treat the underlying sort of causes of atopic dermatitis. And I think that's where we're headed with these wonderful, exciting treatment options. So, that's really the biggest unmet need right now.
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More